abstract |
The present invention relates to the novel compounds of the present invention, pharmaceutically acceptable salts and pharmaceutical compositions thereof useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. The present invention further relates to pharmaceutical compositions of the novel compounds and methods for use in reducing or controlling the production of cortisol in cells or inhibiting the conversion of cortisone to cortisol in cells. |